Alpine Immune Sciences, Inc. (ALPN) Receives Consensus Rating of “Hold” from Analysts

Retrieved on: 2018-03-01 03:58:11

Tags for this article:

Money

Finance

Alpine Immune Sciences Inc.

Click the tags to see associated articles and topics

Alpine Immune Sciences, Inc. (ALPN) Receives Consensus Rating of “Hold” from Analysts. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC boosted its holdings in Alpine Immune Sciences by 29.9% in the 4th quarter. <b>Renaissance Technologies</b> LLC now owns 67,500 shares of the biotechnology company's stock valued at $756,000 after purchasing an additional 15,521 shares during the period. Victory ...</div>

Article found on:

View Original Article